CETP Antibody

1. Studied frequency of two genetic polymorphisms of cholesteryl ester transfer protein (CETP) in a Mongolian population with essential hypertension. PMID: 28425253
2. The I405V polymorphism in the CETP gene is strongly associated with ischemic stroke in a Polish population. PMID: 30078763
3. CETP may play an important role in the development of atherosclerosis mainly by decreasing HDL-C levels and increasing the accumulation of macrophage-derived foam cells PMID: 29317793
4. Our results show an association of this CETP variant at position +82 on HDL cholesterol, levels and adiposity parameters in obese subjects with diabetes mellitus type 2 PMID: 29280647
5. Results demonstrate that CETP expression reduced HDL and increased non-HDL fractions. Also, exercise training reduced CETP plasma levels. These results reinforce the positive metabolic effects of exercise, and resolved a controversy about CETP response to exercise PMID: 29058169
6. APOE4 carriers and the CETP genotype were associated with a decreased response to simvastatin therapy PMID: 28851085
7. Meta-analysis of 6 case-control studies were identified with 1494 cases and 1370 controls. An association of cholesteryl ester transfer protein (CETP) TaqIB polymorphism with ischemic stroke (IS) was found in the 4 genetic models. In the subgroup analysis by ethnicity, similar risks were also observed in Asian population. CETP TaqIB polymorphism is associated with IS risk, and the B2 allele is a protective factor. PMID: 28648960
8. The aggregation analysis revealed a higher correlation between siblings than between parent-offspring pairs representing the role of genetic factors in metabolic syndrome (MetS). In addition, the conditional logistic model with covariates showed that the linkage results between HDL_C and three markers, FTO (rs1558902 and rs7202116) and CETP(rs1864163) were significant. PMID: 29548861
9. Regression analysis revealed significant risk for memory loss that are dependent on age and genetic variants like CETP. PMID: 28777751
10. The -629C allele was significantly associated with an increased risk of Coronary heart disease in Caucasians, and this association may be mediated by its phenotypic regulation on circulating CETP and HDL-C. PMID: 27791990
11. inhibitors, especially Torcetrapib and Anacetrapib, increased the binding ratios of the binary complexes (e.g., HDL-CETP and LDL-CETP) and decreased the binding ratios of the HDL-CETP-LDL ternary complexes. PMID: 28911944
12. Studied association of Cholesterol Ester Transfer Protein (CETP) genetic polymorphisms with acute coronary syndrome; found the frequency of certain genotypes was significantly lower in unstable angina patients, compared with the control group PMID: 28387842
13. Inhibiting cholesteryl ester transfer protein activity inhibits vascular smooth muscle cell proliferation, and reduces neointimal hyperplasia in an scavenger receptor-B1, PDZ domain-containing protein 1- and phosphatidylinositol-3-kinase/Akt-dependent manner. PMID: 29025709
14. The rs1800775, rs3764261, rs12149545, rs711752, and rs708272 polymorphisms of CETP were associated with metabolic syndrome and its components among the Uyghur ethnic group. Complete linkage disequilibrium was found between two pairs of SNPs (rs3764261 and rs12149545, rs711752, and rs708272). PMID: 28629169
15. CETP-inhibition, although effective in improving the lipid profile, is not associated with vascular protective effects as assessed by endothelial function. PMID: 28152406
16. The study identified two polymorphisms with a higher risk of age-related macular degeneration development (AMD) and also a protective polymorphism for AMD. PMID: 28918250
17. CETP TaqIB polymorphism protects against composite ischemic CVD risk and is associated with a higher HDL-C concentration in both Asians and Caucasians (Meta-Analysis) PMID: 27608031
18. Combined exposure to variants in the genes that encode the targets of CETP inhibitors and statins was associated with discordant reductions in LDL-C and apoB levels and a corresponding risk of cardiovascular events that was proportional to the attenuated reduction in apoB but significantly less than expected per unit change in LDL-C. PMID: 28846118
19. Treatment of mildly hypercholesterolemic subjects with CETP inhibitor anacetrapib reduces Lp(a) levels by decreasing its production. PMID: 28729361
20. Carriers of protein-truncating variants of CETP displayed higher high-density lipoprotein cholesterol and lower risk for coronary heart disease. PMID: 28506971
21. Based on results from the study with a relatively large sample size, CETP may be the only detectable locus with common genetic variants that influence HDL-C response to statins substantially in individuals of European descent. Although CETP is known to be associated with HDL-C, the evidence is provided that this pharmacogenetic effect is independent of its association with baseline HDL-C levels. PMID: 27587472
22. The rs1800775 [1.31 (1.22-1.42); p = 3.41E-12] in the CETP gene and rs359027 [1.26 (1.16-1.36); p = 2.55E-08] in the LMCD1 gene were significantly associated with LHDLC levels PMID: 26879886
23. CETP modulates the distribution of spingosine-1-phosphate among lipoproteins, which affects the bioactivities of S1P. PMID: 28126827
24. Anacetrapib treatment increases HDL apoA-I and CETP levels by decreasing the fractional clearance rate of each protein. PMID: 26966279
25. Since expression of CETP has been shown to be positively correlated with the risk of CAD, higher frequency of "A" allele (patients: 22.69% vs.controls: 13%) reveals that c.*84G>A is a risk factor for CAD in South Indians PMID: 27768712
26. CETP V405V genotype was associated with significantly enhanced HDL levels (P = 0.03), mostly owing to the female sex (P = 0.46 for males, P = 0.02 for females), whereas LDL and triglyceride levels were unchanged. PMID: 27439317
27. The single nucleotide polymorphisms in lipoprotein lipase, ApoA5, and CETP were associated with serum triglycerides and HDL-cholesterol levels, but not with coronary artery disease in Pakistani population under study. PMID: 28143480
28. Elevated CETP blood concentration was risk factor for coronary artery disease and correlates with pre beta1-high-density lipoprotein. PMID: 28073362
29. Results show that the bound cholesteryl esters intraconvert between bent and linear conformations in the CETP core tunnel as a consequence of the high degree of conformational flexibility of the protein. PMID: 27445332
30. Daily consumption of policosanol for 8 weeks resulted in lowered blood pressure, reduced serum TG level and CETP activity, and elevated HDL-C contents. PMID: 28259941
31. serum CETP and PLTP activity in patients diagnosed with hypothyroidism, was examined. PMID: 27899788
32. Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism. PMID: 27169917
33. it can be concluded that the effects of the CETP variation on LDL subfraction could change in cardiometabolic events such as coronary heart disease and statin therapy. PMID: 27900488
34. Genetic variants in CETP associated with increased plasma high-density lipoprotein cholesterol raise the risk of intracerebral hemorrhage PMID: 27717122
35. CETP Taq1B Polymorphisms are associated with Hyperlipidemia. PMID: 27590083
36. The study has identified a novel ethnic-specific gene-gene interaction and suggested that the combination of cholesteryl ester transfer protein B1 allele and endothelial nitric oxide synthase 4a allele significantly increases the risk of coronary artery disease in Malays and Indians. PMID: 25667236
37. Both PCSK9 levels and CETP activity were higher in patients with an increasing number of metabolic syndrome components PMID: 27488210
38. Our results suggest that there is no significant association between CETP I405V polymorphism and the risk of coronary artery disease presence and severity PMID: 26773179
39. Data show that polymorphisms of rs662799 and rs2266788 in APOA5 gene, rs320 in LPL gene and rs708272 in CETP gene had significant association with the effect of the lipid-lowering therapy via atorvastatin on ischemic stroke patients. PMID: 27415775
40. Study provides no evidence for CETP gene rs708272 polymorphism association with metabolic syndrome despite its influence on its blood protein concentration. PMID: 27496123
41. results showed that a hydrophobic tunnel inside CETP is sufficient to allow a CE molecule to completely transfer through the entire CETP within a predicted transfer time and at a rate comparable with those obtained through physiological measurements PMID: 27143480
42. SNPs at the CETP, HNF4A and KLF14 locus are associated with HDL-C levels and type 2 diabetes (in female participants). PMID: 26670163
43. Cholesteryl ester transfer between HDL and LDL lipoproteins does not require a ternary tunnel complex with CETP. PMID: 26876146
44. No evidence for clinically relevant associations between several measures of body fat and serum CETP concentration. This finding implies that adipose tissue does not contribute to the CETP pool in serum. PMID: 26820801
45. This is the first report on the association of these polymorphisms with Coronary artery disease (CAD) in Saudi Arabia. The rs5882 polymorphism (CETP) showed a significant association and therefore could be a promising marker for CAD risk PMID: 26936456
46. A single-nucleotide polymorphism in the cholesteryl ester transfer protein (CETP) gene (isoleucine to valine; V405) is associated with slower memory decline and a lower risk of Alzheimer's disease. PMID: 27033407
47. CETP per se has no impact on the glucose tolerance and tissue uptake, global insulin sensitivity and beta cell insulin secretion rates. PMID: 26758205
48. Study suggests that the II genotype of the CETP I405V polymorphism is associated with significant abnormalities in gray matter microstructure compared to those with a V405 allele PMID: 26253899
49. The cholesteryl ester transfer protein (CETP) rs3764261 variant was significantly associated with an increased risk of AMD PMID: 26503844
50. The polymorphism of CETP genes rs708272, rs3764261, rs1800775, rs711752, rs12149545 was closely related to the dyslipidemia in the Xinjiang Uyghur and Kazakh ethnic groups; and the rs708272 T, rs3764261 T, rs711752 A, and rs12149545 A alleles could reduce risk of dyslipidemia in the Uyghur and Kazakh populations, however, the rs1800775 C allele showed risk factors PMID: 26694435

显示更多

收起更多

HGNC: 1869

OMIM: 118470

KEGG: hsa:1071

STRING: 9606.ENSP00000200676

UniGene: Hs.89538